According to news published by Emergo, the medical device market regulators in Colombia have begun allowing automatic renewals for licenses of lower-risk products. Colombia’s medical device market regulator INVIMA implemented a new policy (link in Spanish), whereby registrants that submit applications for renewals to the institute will be granted such requests within three days of receipt rather than within one to two months, as is currently the case for registration renewals. The new policy pertains to Class I and IIa devices.
GHI Analysis
The leading source of MedTech market intelligence in Latin America. Verified data and competitor insights across the key markets in the region. At GHI, we turn hospital data into strategic actions. Our insights help healthcare companies expand by providing accurate, up-to-date information on hospital infrastructure in LATAM and Asia.
Related Posts
Análisis de GHIAnálisis GHI
La «megafarmacia» de la Ciudad de México: ¿Qué significa para las empresas farmacéuticas?
La «megafarmacia» de la Ciudad de México: ¿Qué significa para las empresas farmacéuticas?
Desde que asumió la presidencia a finales de 2018, el presidente mexicano Andrés Manuel López…
Carolina Chazarofebrero 12, 2024
Análisis de GHI
Crecen los registros médicos electrónicos en América Latina
Crecen los registros médicos electrónicos en América Latina
La oportunidad que representa esta tendencia creciente para los fabricantes de equipos y dispositivos médicos
GHI Analysisdiciembre 4, 2017
News
Global neurostimulation device market forecast 2017-2025
Global neurostimulation device market forecast 2017-2025
The global neurostimulation device market was estimated at USD1,902 million in 2016 and expected to…
GHI Analysisjulio 31, 2017